VALORANT player profile · Korea region · Account level 31 · 0 profile views
Current rank: ASCENDANT 2 - 2 RR (as of last recorded competitive match, 2026-05-23).
Peak recorded rank: ASCENDANT 2 - 19 RR (reached 2026-05-22).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 34 |
|---|---|
| Win rate | 64.3% (9 W / 5 L over 14 matches with recorded stats) |
| K/D | 1.15 (219 kills / 191 deaths / 106 assists) |
| Average combat score | 226 |
| Headshot rate | 39.3% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-05-23 | Competitive | Breeze | Astra | L | 9/18/9 | 118 | -17 |
| 2026-05-22 | Competitive | Pearl | Astra | W | 8/16/16 | 120 | +19 |
| 2026-05-22 | Competitive | Split | Clove | L | 10/16/7 | 178 | -18 |
| 2026-05-19 | Competitive | Haven | Sova | W | 17/9/4 | 224 | +20 |
| 2026-05-18 | Competitive | Pearl | Phoenix | W | 17/10/5 | 261 | +24 |
| 2026-05-18 | Competitive | Haven | Clove | L | 22/22/7 | 245 | -16 |
| 2026-05-17 | Competitive | Pearl | Astra | W | 10/9/6 | 155 | +22 |
| 2026-05-17 | Competitive | Lotus | Clove | L | 9/20/3 | 161 | -18 |
| 2026-05-17 | Competitive | Haven | Clove | W | 20/21/12 | 228 | +22 |
| 2026-05-16 | Competitive | Split | Astra | W | 12/4/10 | 199 | +0 |
| 2026-05-16 | Competitive | Fracture | Clove | W | 26/16/8 | 331 | +0 |
| 2026-05-16 | Competitive | Lotus | Clove | W | 20/4/9 | 368 | +0 |
| 2026-05-16 | Competitive | Haven | Clove | W | 22/12/6 | 327 | +0 |
| 2026-05-14 | Competitive | Breeze | Astra | L | 17/14/4 | 249 | +0 |
| 2025-02-20 | Custom | Haven | - | - | - | - | +0 |
| 2024-07-05 | Custom | Sunset | - | - | - | - | +0 |
| 2024-07-05 | Custom | Abyss | - | - | - | - | +0 |
| 2024-06-13 | Custom | Lotus | - | - | - | - | +0 |
| 2024-06-13 | Custom | Icebox | - | - | - | - | +0 |
| 2024-06-13 | Custom | Fracture | - | - | - | - | +0 |
Showing 20 of 34 tracked matches. The interactive profile lists all of them.
No penalty records for this player.